Along with its GLP-1 candidate for treating obesity and type 2 diabetes, Ascendis will also develop, manufacture, and commercialize a cardiovascular-disease product for Novo
Each mouse underwent individual placement in a tank for 6 min
Their study, Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database, was published in the journal Therapeutic Advances in Neurological Disorders
Elia-Amira NMR, Chen CD, Lau KW, Lee HL, Low VL, Norma-Rashid Y, et al
The findings also demonstrate the value of poison center data as a tool for near real-time assessment of emerging post-marketing drug trends
The translation, the translating that principle to your messy, chaotic real life, AI is great at